These findings are partially in line with previous studies showing that uterine cervical or endometrial cancer patients exhibiting TRL, neutrophilia, increased neutrophil-to-lymphocyte ratio, or those with tumor expressing G-CSF are associated with decreased survival rate or resistance to radiotherapy or chemotherapy [21,28,29]. This evidence concerns the gene CSF3 and endometrial cancer.